MÉTHODE DE TRAITEMENT DE PATIENTS ATTEINTS DE CANCER SOUFFRANT D'INSUFFISANCE RÉNALE GRAVE

• 收藏
• 分享

专利权人:

Taiho Pharmaceutical Co.; Ltd.

发明人:

申请号：

EP17747563.9

公开号：

EP3412295A1

申请日:

2017.02.03

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

A method for treating cancer in patients with creatinine clearance of 15 mL/min or more and less than 30 mL/min, including dividing a combination drug containing α,α,α-trifluorothymidine (FTD) and 5-chloro-6-[(2-iminopyrrolidine-1-yl)methyl]pyrimidine-2,4(1H,3H)-dione hydrochloride in a molar ratio of 1 : 0.5, in a dose of 30 to 50 mg/m2/day as FTD-equivalent, into two to four times a day, and orally administering it to the patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/